Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-07-19
2008-12-09
McKane, Joseph (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S540000
Reexamination Certificate
active
07462641
ABSTRACT:
The present invention includes anhydrous crystalline forms of (2S,4S)-4-fluoro-1-[4-fluoro-β-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt.
REFERENCES:
patent: 7132443 (2006-11-01), Haffner et al.
patent: 03/002531 (2003-01-01), None
Augustyns, K. et al., “The Unique Properties of Dipeptidyl-Peptidase IV (DPP IV/CD26) and the Therapeutic Potential of DPP IV Inhibitors,”Current Medicinal Chemistry, V6, N4, 1999, pp. 311-327.
Igo David H
Johnson Paul R
Patterson Daniel E
Randhawa Amarjit Sab
McKane Joseph
Nolan Jason M
SmithKline Beecham Corporation
Thomas R. (Steve)
LandOfFree
(2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenyla... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenyla..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenyla... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4051098